To determine which function of PRL-3 drives tumor initiation and progression, we used transgenic zebrafish models of acute lymphoblastic leukemia (ALL) and rhabdomyosarcoma (RMS), along with human cancer cell lines. The gene discussed is PTP4A3; the disease is rhabdomyosarcoma.